prikaz prve stranice dokumenta Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review
Access restricted to students and staff of home institution
Scientific paper - Case study
Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review
British Journal of Clinical Pharmacology, / (2024); 1-4. https://doi.org/10.1111/bcp.16114
Belančić, Andrej; Hlača, Nika; Peternel, Sandra; Golčić, Marin; Prpić‐Massari, Larisa; Vlahović‐Palčevski, Vera

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Belančić, A., Hlača, N., Peternel, S., Golčić, M., Prpić‐Massari, L. & Vlahović‐Palčevski, V. (2024). Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review. British Journal of Clinical Pharmacology, /., 1-4. doi: 10.1111/bcp.16114

Belančić, Andrej, et al. "Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review." British Journal of Clinical Pharmacology, vol. /, 2024, pp. 1-4. https://doi.org/10.1111/bcp.16114

Belančić, Andrej, Nika Hlača, Sandra Peternel, Marin Golčić, Larisa Prpić‐Massari and Vera Vlahović‐Palčevski. "Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review." British Journal of Clinical Pharmacology / (2024): 1-4. https://doi.org/10.1111/bcp.16114

Belančić, A., et al. (2024) 'Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review', British Journal of Clinical Pharmacology, /, pp. 1-4. doi: 10.1111/bcp.16114

Belančić A, Hlača N, Peternel S, Golčić M, Prpić‐Massari L, Vlahović‐Palčevski V. Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review. British Journal of Clinical Pharmacology [Internet]. 2024 May 27 [cited 2024 July 13];/:1-4. doi: 10.1111/bcp.16114

A. Belančić, N. Hlača, S. Peternel, M. Golčić, L. Prpić‐Massari and V. Vlahović‐Palčevski, "Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review", British Journal of Clinical Pharmacology, vol. /, pp. 1-4, May 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:570684. [Accessed: 13 July 2024]

Metadata
Title (english)Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review
AuthorAndrej Belančić
AuthorNika Hlača
AuthorSandra Peternel
AuthorMarin Golčić
AuthorLarisa Prpić‐Massari
AuthorVera Vlahović‐Palčevski
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Dermatovenerology)
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Pharmacology)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Dermatovenerology
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Clinical Pharmacology and Toxicology
Abstract (english)
We present a 70‐year‐old female patient diagnosed with epidermal growth factor receptor‐mutated metastatic non‐small cell lung cancer (T4N2M1a), who developed afatinib‐induced toxic epidermal necrolysis (TEN). We have also performed a PubMed/Medline literature review to detect other possible cases of TEN/Stevens–Johnson syndrome associated with afatinib treatment and found only 5 other cases reported.
Keywords (english)
Languageenglish
Publication typeScientific paper - Case study
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleBritish Journal of Clinical Pharmacology
Numberingvol. /, pp. 1-4, 16114
p-ISSN0306-5251
e-ISSN1365-2125
DOIhttps://doi.org/10.1111/bcp.16114
URN:NBNurn:nbn:hr:184:570684
Publication2024-05-27
Document URLhttps://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.16114
Type of resourceText
Access conditionsInstitutional access
Terms of useLicence In copyright icon
Created on2024-06-10 10:22:21